Antares Therapeutics Overview
- Year Founded
-
2025
- Status
-
Private
- Employees
-
100
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$177M
- Investors
-
11
Antares Therapeutics General Information
Description
Operator of a biotechnology company intended to develop first-in-class precision medicines targeting previously undruggable cancer and serious disease targets. The company offers an integrated drug discovery platform combining advanced computational chemistry, predictive sciences and experimental biology, enabling the development of transformative therapies for patients with high unmet medical needs.
Contact Information
Website
www.antaresrx.comCorporate Office
- 1 Winthrop Square
- Suite 400
- Boston, MA 02110
- United States
Corporate Office
- 1 Winthrop Square
- Suite 400
- Boston, MA 02110
- United States
Antares Therapeutics Timeline
Antares Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC (Series A) | 30-Apr-2025 | $177M | Completed | Pre-Clinical Trials | ||
| 1. Spin-Off | 12-Mar-2025 | Completed | Pre-Clinical Trials |
Antares Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-2 | ||||||||
| Series A-1 |
Antares Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Antares Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Antares Therapeutics Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Abingworth | Venture Capital | Minority | ||
| Atlas Venture | Venture Capital | Minority | ||
| BVF Partners | Hedge Fund | Minority | ||
| Cormorant Asset Management | PE/Buyout | Minority | ||
| Invus Opportunities | Venture Capital | Minority |
Antares Therapeutics FAQs
-
When was Antares Therapeutics founded?
Antares Therapeutics was founded in 2025.
-
Where is Antares Therapeutics headquartered?
Antares Therapeutics is headquartered in Boston, MA.
-
What is the size of Antares Therapeutics?
Antares Therapeutics has 100 total employees.
-
What industry is Antares Therapeutics in?
Antares Therapeutics’s primary industry is Biotechnology.
-
Is Antares Therapeutics a private or public company?
Antares Therapeutics is a Private company.
-
What is the current valuation of Antares Therapeutics?
The current valuation of Antares Therapeutics is .
-
What is Antares Therapeutics’s current revenue?
The current revenue for Antares Therapeutics is .
-
How much funding has Antares Therapeutics raised over time?
Antares Therapeutics has raised $177M.
-
Who are Antares Therapeutics’s investors?
Abingworth, Atlas Venture, BVF Partners, Cormorant Asset Management, and Invus Opportunities are 5 of 11 investors who have invested in Antares Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
